{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "14",
                "@timestamp": "2023-07-14T01:52:28.000028-04:00",
                "@year": "2023",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "02"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Chulabhorn Hospital"},
                {"xocs:funding-agency-matched-string": "Medica Innova Co. Ltd"},
                {"xocs:funding-agency-matched-string": "Medica Innova Co., Ltd."},
                {
                    "xocs:funding-agency-matched-string": "Chulabhorn Royal Academy",
                    "xocs:funding-agency-acronym": "CRA",
                    "xocs:funding-agency": "Chulabhorn Royal Academy",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100016175",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn University",
                    "xocs:funding-agency-acronym": "CU",
                    "xocs:funding-agency": "Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-01-16T10:10:08.485Z",
            "xocs:funding-text": [
                {"$": "This work was jointly supported by Chulabhorn Hospital, Chulabhorn Royal Academy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, and Medica Innova Co., Ltd. We also thank Dr. Mitr Pathipvanich for his review and comments on the formulation studies of this work."},
                {"$": "This work was jointly supported by Chulabhorn Hospital, Chulabhorn Royal Academy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, and Medica Innova Co. Ltd. We also thank Dr. Mitr Pathipvanich for his review and comments on the formulation studies of this work."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "address-part": "Bangkok",
                            "postal-code": "10330",
                            "@afid": "60028190",
                            "@country": "tha",
                            "organization": [
                                {"$": "Department of Food and Pharmaceutical Chemistry"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "104425859"
                            },
                            "@affiliation-instance-id": "S0022354922005081-021e02ef55f7b712c8acdeedae0c7fe0",
                            "ce:source-text": "aDepartment of Food and Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand",
                            "@dptid": "104425859"
                        },
                        "author": [
                            {
                                "ce:given-name": "Bodin",
                                "preferred-name": {
                                    "ce:given-name": "Bodin",
                                    "ce:initials": "B.",
                                    "ce:surname": "Tuesuwan",
                                    "ce:indexed-name": "Tuesuwan B."
                                },
                                "@author-instance-id": "OB2BibRecID-944454771-dd25abe82816eb3b0dc6d7a575d7575b-1",
                                "@seq": "1",
                                "ce:initials": "B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Tuesuwan",
                                "@auid": "6504614303",
                                "ce:indexed-name": "Tuesuwan B."
                            },
                            {
                                "ce:given-name": "Vorasit",
                                "preferred-name": {
                                    "ce:given-name": "Vorasit",
                                    "ce:initials": "V.",
                                    "ce:surname": "Vongsutilers",
                                    "ce:indexed-name": "Vongsutilers V."
                                },
                                "@author-instance-id": "OB2BibRecID-944454771-06614ba03dc02991ef5766edd5c88958-1",
                                "@seq": "9",
                                "ce:initials": "V.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Vongsutilers",
                                "@auid": "36783652300",
                                "@orcid": "0000-0002-5352-7506",
                                "ce:indexed-name": "Vongsutilers V."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "address-part": "Bangkok",
                            "postal-code": "10310",
                            "@afid": "127008786",
                            "@country": "tha",
                            "organization": [
                                {"$": "Medica Innova Co."},
                                {"$": "Ltd."}
                            ],
                            "affiliation-id": {"@afid": "127008786"},
                            "@affiliation-instance-id": "S0022354922005081-5af0e40507b8e62cc9bcc1e75f6b5f14",
                            "ce:source-text": "bMedica Innova Co., Ltd., Bangkok, 10310, Thailand"
                        },
                        "author": [
                            {
                                "ce:given-name": "Wunlapa",
                                "preferred-name": {
                                    "ce:given-name": "Wunlapa",
                                    "ce:initials": "W.",
                                    "ce:surname": "Mueannoom",
                                    "ce:indexed-name": "Mueannoom W."
                                },
                                "@author-instance-id": "OB2BibRecID-944454771-32ef63f96f0e50f6f49ae833956cee9e-1",
                                "@seq": "2",
                                "ce:initials": "W.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Mueannoom",
                                "@auid": "36340610800",
                                "ce:indexed-name": "Mueannoom W."
                            },
                            {
                                "ce:given-name": "Promporn",
                                "preferred-name": {
                                    "ce:given-name": "Promporn",
                                    "ce:initials": "P.",
                                    "ce:surname": "Jamnongtanachot",
                                    "ce:indexed-name": "Jamnongtanachot P."
                                },
                                "@author-instance-id": "OB2BibRecID-944454771-29725e90859d715dce476610ed9c89ad-1",
                                "@seq": "3",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Jamnongtanachot",
                                "@auid": "57812104000",
                                "ce:indexed-name": "Jamnongtanachot P."
                            },
                            {
                                "ce:given-name": "Ariya",
                                "preferred-name": {
                                    "ce:given-name": "Ariya",
                                    "ce:initials": "A.",
                                    "ce:surname": "Khunvichai",
                                    "ce:indexed-name": "Khunvichai A."
                                },
                                "@author-instance-id": "OB2BibRecID-944454771-30ca5103bd6549da2ca6a5ab5e01ae06-1",
                                "@seq": "4",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Khunvichai",
                                "@auid": "24179362700",
                                "ce:indexed-name": "Khunvichai A."
                            },
                            {
                                "ce:given-name": "Chiravi",
                                "preferred-name": {
                                    "ce:given-name": "Chiravi",
                                    "ce:initials": "C.",
                                    "ce:surname": "Pavitrapok",
                                    "ce:indexed-name": "Pavitrapok C."
                                },
                                "@author-instance-id": "OB2BibRecID-944454771-7e80d759ebe9e39d562e8b654e2e46be-1",
                                "@seq": "5",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Pavitrapok",
                                "@auid": "12244858700",
                                "ce:indexed-name": "Pavitrapok C."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "address-part": "Bangkok",
                            "postal-code": "10210",
                            "@afid": "60022464",
                            "@country": "tha",
                            "organization": [
                                {"$": "Chulabhorn Hospital"},
                                {"$": "Chulabhorn Royal Academy"}
                            ],
                            "affiliation-id": {"@afid": "60022464"},
                            "@affiliation-instance-id": "S0022354922005081-b5390321c9bfacac437914863a5e7cee",
                            "ce:source-text": "cChulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, 10210, Thailand"
                        },
                        "author": [
                            {
                                "ce:given-name": "Kawinthida",
                                "preferred-name": {
                                    "ce:given-name": "Kawinthida",
                                    "ce:initials": "K.",
                                    "ce:surname": "Wongpakdee",
                                    "ce:indexed-name": "Wongpakdee K."
                                },
                                "@author-instance-id": "OB2BibRecID-944454771-5c4d92c2fbe2128aa2b568dfbc6a8dd4-1",
                                "@seq": "6",
                                "ce:initials": "K.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wongpakdee",
                                "@auid": "57812103900",
                                "ce:indexed-name": "Wongpakdee K."
                            },
                            {
                                "ce:given-name": "Supasil",
                                "preferred-name": {
                                    "ce:given-name": "Supasil",
                                    "ce:initials": "S.",
                                    "ce:surname": "Sra-ium",
                                    "ce:indexed-name": "Sra-ium S."
                                },
                                "@author-instance-id": "OB2BibRecID-944454771-8c4b32afe5209c3ff7f8b540b81151dd-1",
                                "@seq": "7",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sra-ium",
                                "@auid": "23092189800",
                                "ce:indexed-name": "Sra-ium S."
                            },
                            {
                                "ce:given-name": "Nithi",
                                "preferred-name": {
                                    "ce:given-name": "Nithi",
                                    "ce:initials": "N.",
                                    "ce:surname": "Mahanonda",
                                    "ce:indexed-name": "Mahanonda N."
                                },
                                "@author-instance-id": "OB2BibRecID-944454771-2438e015647ed013428c51f8000833d0-1",
                                "@seq": "8",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Mahanonda",
                                "@auid": "7007170188",
                                "@orcid": "0000-0003-4473-4121",
                                "ce:indexed-name": "Mahanonda N."
                            }
                        ]
                    }
                ],
                "citation-title": "Basis to Aid Crisis: Favipiravir Oral Solution for Hospital Compounding During COVID-19 Drug Shortage",
                "abstracts": "© 2022 American Pharmacists AssociationThe COVID-19 pandemic outbreak has been overwhelming the healthcare system worldwide. A rapidly growing number of younger pediatric patients in Thailand necessitated the formulation of favipiravir, the most locally accessible antiviral agent against COVID-19, into a child-friendly dosage form as a safer alternative to a dispersion of crushed tablets in simple syrup. While striving to quickly develop a liquid formulation that is feasible for any local hospital production units, an oral solution was chosen due to its simplicity. Despite the large dose and poor aqueous solubility of favipiravir, a combination of pH control and use of poloxamer as a solubilizing agent has enabled us to streamline the manufacturing process of a 200 mg/15 mL oral solution for hospital compounding. To ensure its efficacy and safety, a specification for quality control was also established in accordance with the ICH quality guidelines and USP. The finished product stability was subsequently demonstrated under the conditions of 5°C ± 3°C, 25°C ± 2°C/75% RH ± 5% RH, 30°C ± 2°C/75% RH ± 5% RH, and 40°C ± 2°C/75% RH ± 5% RH. The results indicated that our formulation can be stored at 30°C ± 2°C/75% RH for 30 days, which will very well serve the need to allow drug distribution and patient use during the crisis, while the shelf-life can be extended to 60 days when stored at 5°C ± 3°C. Thus, accessibility to an essential medical treatment has been successfully enhanced for pediatric patients in Thailand and neighboring countries during the COVID-19 outbreak.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "address-part": "254 Phayathai Rd, Bangkok",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Pathumwan",
                        "organization": [
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "@affiliation-instance-id": "OB2BibRecID-944454771-81602e7f829b3e9b6bfbcc9e51c907e1-1"
                    },
                    "person": {
                        "ce:given-name": "Vorasit",
                        "@author-instance-id": "OB2BibRecID-944454771-b968aad9b6b23ae9fc704cc7dab13c97-1",
                        "ce:initials": "V.",
                        "ce:surname": "Vongsutilers",
                        "ce:indexed-name": "Vongsutilers V."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "COVID-19",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Favipiravir",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Formulation development",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Hospital compounding",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Oral solution",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Specification",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Stability",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "www.interscience.wiley.com/jpages/0022-3549",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of Pharmaceutical Sciences",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "112",
                            "@issue": "2"
                        },
                        "pagerange": {
                            "@first": "610",
                            "@last": "617"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of Pharmaceutical Sciences",
                    "publicationdate": {
                        "month": "02",
                        "year": "2023",
                        "date-text": "February 2023",
                        "day": "01"
                    },
                    "codencode": "JPMSA",
                    "sourcetitle-abbrev": "J. Pharm. Sci.",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "15206017",
                            "@type": "electronic"
                        },
                        {
                            "$": "00223549",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "Elsevier B.V."},
                    "@srcid": "23079"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "27",
                                    "classification-description": "Biophysics, Bioengineering and Medical Instrumentation"
                                },
                                {
                                    "classification-code": "30",
                                    "classification-description": "Clinical and Experimental Pharmacology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "4",
                                    "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "3003"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "PHAR"
                        }
                    ]},
                    "tradenamegroup": {"tradenames": {
                        "trademanuitem": [
                            {
                                "tradename": "LC-20AD",
                                "manufacturer": {
                                    "@country": "jpn",
                                    "$": "Shimadzu"
                                }
                            },
                            {
                                "tradename": "Model827",
                                "manufacturer": {
                                    "@country": "che",
                                    "$": "Metrohm"
                                }
                            },
                            {
                                "tradename": "XP26DR",
                                "manufacturer": {
                                    "@country": "che",
                                    "$": "Mettler"
                                }
                            }
                        ],
                        "@type": "TNV"
                    }},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "75-05-8",
                                    "chemical-name": "acetonitrile"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "22839-47-0"},
                                        {"$": "5910-52-1"}
                                    ],
                                    "chemical-name": "aspartame"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "18996-35-5"},
                                        {"$": "994-36-5"}
                                    ],
                                    "chemical-name": "citrate sodium"
                                },
                                {
                                    "cas-registry-number": "259793-96-9",
                                    "chemical-name": "favipiravir"
                                },
                                {
                                    "cas-registry-number": "99-76-3",
                                    "chemical-name": "methyl paraben"
                                },
                                {
                                    "cas-registry-number": "9003-11-6",
                                    "chemical-name": "poloxamer"
                                },
                                {
                                    "cas-registry-number": "94-13-3",
                                    "chemical-name": "propyl paraben"
                                },
                                {
                                    "cas-registry-number": "1310-73-2",
                                    "chemical-name": "sodium hydroxide"
                                },
                                {
                                    "cas-registry-number": "17655-31-1",
                                    "chemical-name": "amide"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Amides"},
                                {"chemical-name": "favipiravir"}
                            ]
                        }
                    ]},
                    "manufacturergroup": {"manufacturers": [
                        {
                            "@type": "MNF",
                            "manufacturer": [
                                {
                                    "@country": "deu",
                                    "$": "Merck"
                                },
                                {
                                    "@country": "usa",
                                    "$": "BASF Corporaion"
                                },
                                {"$": "Raghava Life Sciences"}
                            ]
                        },
                        {
                            "@type": "MNV",
                            "manufacturer": [
                                {
                                    "@country": "che",
                                    "$": "Metrohm"
                                },
                                {
                                    "@country": "che",
                                    "$": "Mettler"
                                },
                                {
                                    "@country": "jpn",
                                    "$": "Shimadzu"
                                }
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This work was jointly supported by Chulabhorn Hospital, Chulabhorn Royal Academy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, and Medica Innova Co. Ltd. We also thank Dr. Mitr Pathipvanich for his review and comments on the formulation studies of this work.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "CHEM"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYS"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "21",
                    "@timestamp": "BST 13:08:11",
                    "@year": "2023",
                    "@month": "03"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2021225157",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "639449730",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "944454771",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "2022270137",
                            "@idtype": "CHEM"
                        },
                        {
                            "$": "20221079494",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "36334809",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2022287057",
                            "@idtype": "REAXYS"
                        },
                        {
                            "$": "20223473892",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2022547534",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20224193010",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85142751937",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85142751937",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "639449730",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76476999",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S0022354922005081",
                    "ce:ern": "pii:S0022354922005081",
                    "ce:doi": "10.1016/j.xphs.2022.10.026"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "21",
                "reference": [
                    {
                        "ref-fulltext": "Furuta, Y, Komeno, T, Nakamura, T., Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B 93:7 (2017), 449\u2013463, 10.2183/pjab.93.027.",
                        "@reference-instance-id": "OB2BibRecID-944454771-7d91da7a0d433e69254b49a8b4488ad3-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2183/pjab.93.027",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85026639600",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "93",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "449",
                                    "@last": "463"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Furuta",
                                    "ce:indexed-name": "Furuta Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Komeno",
                                    "ce:indexed-name": "Komeno T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Nakamura",
                                    "ce:indexed-name": "Nakamura T."
                                }
                            ]},
                            "ref-sourcetitle": "Proc Jpn Acad Ser B"
                        },
                        "ce:source-text": "Furuta Y, Komeno T, Nakamura T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B. 2017;93(7):449-463. doi:10.2183/pjab.93.027"
                    },
                    {
                        "ref-fulltext": "Avigan Tablets 200 mg. 2022, Medical Information Center, Taisho Toyama Pharmaceutical Co. L https://www.cdc.gov.tw/File/Get/ht8jUiB_MI-aKnlwstwzvw Published 2017. Accessed April 15, 2022.",
                        "@reference-instance-id": "OB2BibRecID-944454771-eb8b6dd24901fb821afd3ba90d86c4de-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.cdc.gov.tw/File/Get/ht8jUiB_MI-aKnlwstwzvw",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Avigan Tablets 200 mg"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85142716509",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Medical Information Center, Taisho Toyama Pharmaceutical Co. L Published 2017. Accessed April 15, 2022"
                        },
                        "ce:source-text": "Medical Information Center, Taisho Toyama Pharmaceutical Co. L. Avigan Tablets 200 mg. https://www.cdc.gov.tw/File/Get/ht8jUiB_MI-aKnlwstwzvw. Published 2017. Accessed April 15, 2022."
                    },
                    {
                        "ref-fulltext": "Sissoko, D, Laouenan, C, Folkesson, E, et al. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLOS Med, 13(3), 2016, e1001967, 10.1371/journal.pmed.1001967.",
                        "@reference-instance-id": "OB2BibRecID-944454771-4358e8f55da03e13e7df6f68f0475437-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pmed.1001967",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e1001967",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "84962128607",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "13",
                                "@issue": "3"
                            }},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Sissoko",
                                        "ce:indexed-name": "Sissoko D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Laouenan",
                                        "ce:indexed-name": "Laouenan C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Folkesson",
                                        "ce:indexed-name": "Folkesson E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLOS Med"
                        },
                        "ce:source-text": "Sissoko D, Laouenan C, Folkesson E, et al. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLOS Med. 2016;13(3):e1001967. https://doi.org/10.1371/journal.pmed.1001967."
                    },
                    {
                        "ref-fulltext": "Bai, C-Q, Mu, J-S, Kargbo, D, et al. Clinical and virological characteristics of ebola virus disease patients treated with favipiravir (T-705)-Sierra Leone, 2014. Clin Infect Dis 63:10 (2016), 1288\u20131294, 10.1093/cid/ciw571.",
                        "@reference-instance-id": "OB2BibRecID-944454771-a22cb36c350220a6953f1861b1943e78-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Clinical and virological characteristics of ebola virus disease patients treated with favipiravir (T-705)-Sierra Leone, 2014"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/cid/ciw571",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84994408776",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "63",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1288",
                                    "@last": "1294"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "ce:given-name": "C-Q",
                                        "@seq": "1",
                                        "ce:initials": "C.-Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Bai",
                                        "ce:indexed-name": "Bai C.-Q."
                                    },
                                    {
                                        "ce:given-name": "J-S",
                                        "@seq": "2",
                                        "ce:initials": "J.-S.",
                                        "@_fa": "true",
                                        "ce:surname": "Mu",
                                        "ce:indexed-name": "Mu J.-S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Kargbo",
                                        "ce:indexed-name": "Kargbo D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Bai C-Q, Mu J-S, Kargbo D, et al. Clinical and virological characteristics of ebola virus disease patients treated with favipiravir (T-705)-Sierra Leone, 2014. Clin Infect Dis. 2016;63(10):1288-1294. doi:10.1093/cid/ciw571"
                    },
                    {
                        "ref-fulltext": "Ivashchenko, AA, Dmitriev, KA, Vostokova, N V, et al. AVIFAVIR for treatment of patients with moderate coronavirus disease 2019 (COVID-19): interim results of a phase II/III multicenter randomized clinical trial. Clin Infect Dis 73:3 (2021), 531\u2013534, 10.1093/cid/ciaa1176.",
                        "@reference-instance-id": "OB2BibRecID-944454771-befb712972b7dbd6473691b850f96137-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "AVIFAVIR for treatment of patients with moderate coronavirus disease 2019 (COVID-19): interim results of a phase II/III multicenter randomized clinical trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/cid/ciaa1176",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85113710617",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "73",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "531",
                                    "@last": "534"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Ivashchenko",
                                        "ce:indexed-name": "Ivashchenko A.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dmitriev",
                                        "ce:indexed-name": "Dmitriev K.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Vostokova",
                                        "ce:indexed-name": "Vostokova N.V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Ivashchenko AA, Dmitriev KA, Vostokova N V, et al. AVIFAVIR for treatment of patients with moderate coronavirus disease 2019 (COVID-19): interim results of a phase II/III multicenter randomized clinical trial. Clin Infect Dis. 2021;73(3):531-534. doi:10.1093/cid/ciaa1176"
                    },
                    {
                        "ref-fulltext": "Manabe, T, Kambayashi, D, Akatsu, H, Kudo, K., Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis, 21(1), 2021, 489, 10.1186/s12879-021-06164-x.",
                        "@reference-instance-id": "OB2BibRecID-944454771-53716fa42027c3498d6e9c6ba1fa7989-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s12879-021-06164-x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85107004973",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "489"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Manabe",
                                    "ce:indexed-name": "Manabe T."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Kambayashi",
                                    "ce:indexed-name": "Kambayashi D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Akatsu",
                                    "ce:indexed-name": "Akatsu H."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Kudo",
                                    "ce:indexed-name": "Kudo K."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Infect Dis"
                        },
                        "ce:source-text": "Manabe T, Kambayashi D, Akatsu H, Kudo K. Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):489. doi:10.1186/s12879-021-06164-x"
                    },
                    {
                        "ref-fulltext": "Udwadia, ZF, Singh, P, Barkate, H, et al. Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial. Int J Infect Dis 103 (2021), 62\u201371, 10.1016/j.ijid.2020.11.142.",
                        "@reference-instance-id": "OB2BibRecID-944454771-4921bf33b8f568c8a185588df983c7cd-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.ijid.2020.11.142",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85098185286",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "103"},
                                "pagerange": {
                                    "@first": "62",
                                    "@last": "71"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Z.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Udwadia",
                                        "ce:indexed-name": "Udwadia Z.F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Singh",
                                        "ce:indexed-name": "Singh P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Barkate",
                                        "ce:indexed-name": "Barkate H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Infect Dis"
                        },
                        "ce:source-text": "Udwadia ZF, Singh P, Barkate H, et al. Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial. Int J Infect Dis. 2021;103:62-71. doi:10.1016/j.ijid.2020.11.142"
                    },
                    {
                        "ref-fulltext": "Fujii, S, Ibe, Y, Ishigo, T, et al. Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients. J Infect Chemother 27:7 (2021), 1051\u20131057, 10.1016/j.jiac.2021.04.013.",
                        "@reference-instance-id": "OB2BibRecID-944454771-0bdea932b3a518446a3f4ff26db9b15e-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jiac.2021.04.013",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85106308055",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "1051",
                                    "@last": "1057"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Fujii",
                                        "ce:indexed-name": "Fujii S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Ibe",
                                        "ce:indexed-name": "Ibe Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Ishigo",
                                        "ce:indexed-name": "Ishigo T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Infect Chemother"
                        },
                        "ce:source-text": "Fujii S, Ibe Y, Ishigo T, et al. Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients. J Infect Chemother. 2021;27(7):1051-1057. doi:10.1016/j.jiac.2021.04.013"
                    },
                    {
                        "ref-fulltext": "Karatas, E, Aksoy, L, Ozaslan, E., Association of early favipiravir use with reduced COVID-19 fatality among hospitalized patients. Infect Chemother 53:2 (2021), 300\u2013307, 10.3947/ic.2020.0149.",
                        "@reference-instance-id": "OB2BibRecID-944454771-4fcb9861f57950d7963e7ad4b05f322d-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Association of early favipiravir use with reduced COVID-19 fatality among hospitalized patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3947/ic.2020.0149",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85110306682",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "53",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "300",
                                    "@last": "307"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Karatas",
                                    "ce:indexed-name": "Karatas E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Aksoy",
                                    "ce:indexed-name": "Aksoy L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Ozaslan",
                                    "ce:indexed-name": "Ozaslan E."
                                }
                            ]},
                            "ref-sourcetitle": "Infect Chemother"
                        },
                        "ce:source-text": "Karatas E, Aksoy L, Ozaslan E. Association of early favipiravir use with reduced COVID-19 fatality among hospitalized patients. Infect Chemother. 2021;53(2):300-307. doi:10.3947/ic.2020.0149"
                    },
                    {
                        "ref-fulltext": "Department of Medical Service, Guidelines for Clinical Practice, Diagnosis, Treatment and Prevention of Healthcare-Associated Infection in Response to Patients with COVID-19 Infection. 2022 https://covid19.dms.go.th/Content/Select_Content_Grid_Home_7_8?contentCategoryId=8 Published 2021. Accessed July 15.",
                        "@reference-instance-id": "OB2BibRecID-944454771-1fa49446b526eee6f408fc013d0c5cb2-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://covid19.dms.go.th/Content/Select_Content_Grid_Home_7_8?contentCategoryId=8",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Guidelines for Clinical Practice, Diagnosis, Treatment and Prevention of Healthcare-Associated Infection in Response to Patients with COVID-19 Infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85142727126",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Published 2021. Accessed July 15",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "@_fa": "true",
                                "ce:surname": "Department of Medical Service",
                                "ce:indexed-name": "Department of Medical Service"
                            }]}
                        },
                        "ce:source-text": "Department of Medical Service. Guidelines for Clinical Practice, Diagnosis, Treatment and Prevention of Healthcare-Associated Infection in Response to Patients with COVID-19 Infection. https://covid19.dms.go.th/Content/Select_Content_Grid_Home_7_8?contentCategoryId=8. Published 2021. Accessed July 15, 2022."
                    },
                    {
                        "ref-fulltext": "The international council for harmonisation of technical requirements for pharmaceuticals for human Use (ICH). ICH Q6A - Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances, 1999.",
                        "@reference-instance-id": "OB2BibRecID-944454771-d47ec3976c65e20ef98054d3a7fb6ef2-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1999"},
                            "ref-title": {"ref-titletext": "The international council for harmonisation of technical requirements for pharmaceuticals for human Use (ICH)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85145957917",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "ICH Q6A - Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances"
                        },
                        "ce:source-text": "The international council for harmonisation of technical requirements for pharmaceuticals for human Use (ICH). ICH Q6A - Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances.; 1999."
                    },
                    {
                        "ref-fulltext": "The United State Pharmacopeia. 〈791〉 pH. USP-NF, 2022.",
                        "@reference-instance-id": "OB2BibRecID-944454771-72ff39157668672cd52fb9337916fae0-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "The United State Pharmacopeia. 〈791〉 pH"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85142768000",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "USP-NF"
                        },
                        "ce:source-text": "The United State Pharmacopeia. 〈791〉 pH. In: USP-NF.; 2022."
                    },
                    {
                        "ref-fulltext": "The United State Pharmacopeia. 〈61〉 Microbiological examination of nonsterile products: microbial enumeration tests. USP-NF, 2022.",
                        "@reference-instance-id": "OB2BibRecID-944454771-8b3b6fa062880d75c94071ee0aab7b38-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "The United State Pharmacopeia. 〈61〉 Microbiological examination of nonsterile products: microbial enumeration tests"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85142684418",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "USP-NF"
                        },
                        "ce:source-text": "The United State Pharmacopeia. 〈61〉 Microbiological examination of nonsterile products: microbial enumeration tests. In: USP-NF.; 2022."
                    },
                    {
                        "ref-fulltext": "The International Council for harmonisation of technical requirements for pharmaceuticals for human use (ICH). ICH Q1A(R2) - Stability Testing of New Drug Substances and Products, 2003.",
                        "@reference-instance-id": "OB2BibRecID-944454771-2245b62e37701fda7edf4d5ade896bc6-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "The International Council for harmonisation of technical requirements for pharmaceuticals for human use (ICH)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85142725903",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "ICH Q1A(R2) - Stability Testing of New Drug Substances and Products"
                        },
                        "ce:source-text": "The International Council for harmonisation of technical requirements for pharmaceuticals for human use (ICH). ICH Q1A(R2) - Stability Testing of New Drug Substances and Products; 2003."
                    },
                    {
                        "ref-fulltext": "Japanese Pharmaceuticals and Medical Devices Agency. Report on the Deliberation Results: Avigan Tablet 200 Mg, 2014 https://www.pmda.go.jp/files/000210319.pdf.",
                        "@reference-instance-id": "OB2BibRecID-944454771-fdd2c2ab95026a85a8cc5253737d2c6f-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.pmda.go.jp/files/000210319.pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Japanese Pharmaceuticals and Medical Devices Agency"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85142745629",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "Report on the Deliberation Results: Avigan Tablet 200 Mg"
                        },
                        "ce:source-text": "Japanese Pharmaceuticals and Medical Devices Agency. Report on the Deliberation Results: Avigan Tablet 200 Mg.; 2014. https://www.pmda.go.jp/files/000210319.pdf."
                    },
                    {
                        "ref-fulltext": "Siripongboonsitti, T, Ungtrakul, T, Watanapokasin, N, et al. Pharmacokinetic comparison of favipiravir oral solution and tablet formulations in healthy Thai Volunteers. Clin Pharmacol Drug Dev, 2022, 10.1002/cpdd.1149 in press(in press).",
                        "@reference-instance-id": "OB2BibRecID-944454771-6b18e56acdfd16d6f17334d22e31438a-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic comparison of favipiravir oral solution and tablet formulations in healthy Thai Volunteers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/cpdd.1149",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85134610527",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "in press(in press)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Siripongboonsitti",
                                        "ce:indexed-name": "Siripongboonsitti T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Ungtrakul",
                                        "ce:indexed-name": "Ungtrakul T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Watanapokasin",
                                        "ce:indexed-name": "Watanapokasin N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacol Drug Dev"
                        },
                        "ce:source-text": "Siripongboonsitti T, Ungtrakul T, Watanapokasin N, et al. Pharmacokinetic comparison of favipiravir oral solution and tablet formulations in healthy Thai Volunteers. Clin Pharmacol Drug Dev. 2022;in press(in press). doi:https://doi.org/10.1002/cpdd.1149"
                    },
                    {
                        "ref-fulltext": "World Health Organization (WHO), IMWP Monographs on Favipiravir and on Favipiravir Tablets. 2021 https://cdn.who.int/media/docs/default-source/medicines/imwp-favipiravir-monographs.pdf?sfvrsn=212299e1_19&download=true.",
                        "@reference-instance-id": "OB2BibRecID-944454771-5cccb9be3a7a35cb4349a2a10af394c6-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://cdn.who.int/media/docs/default-source/medicines/imwp-favipiravir-monographs.pdf?sfvrsn=212299e1_19&download=true",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "IMWP Monographs on Favipiravir and on Favipiravir Tablets"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85145958251",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "@_fa": "true",
                                "ce:surname": "World Health Organization (WHO)",
                                "ce:indexed-name": "World Health Organization (WHO)"
                            }]}
                        },
                        "ce:source-text": "World Health Organization (WHO). IMWP Monographs on Favipiravir and on Favipiravir Tablets.; 2021. https://cdn.who.int/media/docs/default-source/medicines/imwp-favipiravir-monographs.pdf?sfvrsn=212299e1_19&download=true."
                    },
                    {
                        "ref-fulltext": "The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Q3B (R2) Impurities in New Drug Products, 2006.",
                        "@reference-instance-id": "OB2BibRecID-944454771-2d338b29410c36b746aab73a15e73f5e-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85142750879",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "ICH Q3B (R2) Impurities in New Drug Products"
                        },
                        "ce:source-text": "The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Q3B (R2) Impurities in New Drug Products.; 2006."
                    },
                    {
                        "ref-fulltext": "The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk - Step 5, 2017.",
                        "@reference-instance-id": "OB2BibRecID-944454771-231a590b9b8bf6edbabea73ace2a820c-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85142686307",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "ICH M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk - Step 5"
                        },
                        "ce:source-text": "The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk - Step 5.; 2017."
                    },
                    {
                        "ref-fulltext": "The United State Pharmacopeia. <1111>Microbiological examination of nonsterile products: acceptance criteria for pharmaceutical preparations and substances for pharmaceutical use. USP-NF, 2022.",
                        "@reference-instance-id": "OB2BibRecID-944454771-be32a051139bc055c8267da1e2dc3009-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "<1111>Microbiological examination of nonsterile products: acceptance criteria for pharmaceutical preparations and substances for pharmaceutical use"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85142740639",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "The United State Pharmacopeia",
                                "ce:indexed-name": "The United State Pharmacopeia"
                            }},
                            "ref-sourcetitle": "USP-NF"
                        },
                        "ce:source-text": "The United State Pharmacopeia. <1111>Microbiological examination of nonsterile products: acceptance criteria for pharmaceutical preparations and substances for pharmaceutical use. In: USP-NF; 2022."
                    },
                    {
                        "ref-fulltext": "Vemuri, DK, Gundla, R, Konduru, N, Mallavarapu, R, Katari, NK., Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC\u2013MS method. Biomed Chromatogr, 36(6), 2022, e5363, 10.1002/bmc.5363.",
                        "@reference-instance-id": "OB2BibRecID-944454771-fdbbc075096847c04e871e2374cbe8f4-21",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC\u2013MS method"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/bmc.5363",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85127640458",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "6"
                                },
                                "pagerange": {"@first": "e5363"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Vemuri",
                                    "ce:indexed-name": "Vemuri D.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Gundla",
                                    "ce:indexed-name": "Gundla R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Konduru",
                                    "ce:indexed-name": "Konduru N."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Mallavarapu",
                                    "ce:indexed-name": "Mallavarapu R."
                                },
                                {
                                    "ce:given-name": "NK.",
                                    "@seq": "5",
                                    "ce:initials": "N.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Katari",
                                    "ce:indexed-name": "Katari N.K."
                                }
                            ]},
                            "ref-sourcetitle": "Biomed Chromatogr"
                        },
                        "ce:source-text": "Vemuri DK, Gundla R, Konduru N, Mallavarapu R, Katari NK. Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC\u2013MS method. Biomed Chromatogr. 2022;36(6):e5363. https://doi.org/10.1002/bmc.5363"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022464",
            "affilname": "Chulabhorn Royal Academy",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022464",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "127008786",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127008786",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85142751937",
        "dc:description": "The COVID-19 pandemic outbreak has been overwhelming the healthcare system worldwide. A rapidly growing number of younger pediatric patients in Thailand necessitated the formulation of favipiravir, the most locally accessible antiviral agent against COVID-19, into a child-friendly dosage form as a safer alternative to a dispersion of crushed tablets in simple syrup. While striving to quickly develop a liquid formulation that is feasible for any local hospital production units, an oral solution was chosen due to its simplicity. Despite the large dose and poor aqueous solubility of favipiravir, a combination of pH control and use of poloxamer as a solubilizing agent has enabled us to streamline the manufacturing process of a 200 mg/15 mL oral solution for hospital compounding. To ensure its efficacy and safety, a specification for quality control was also established in accordance with the ICH quality guidelines and USP. The finished product stability was subsequently demonstrated under the conditions of 5°C ± 3°C, 25°C ± 2°C/75% RH ± 5% RH, 30°C ± 2°C/75% RH ± 5% RH, and 40°C ± 2°C/75% RH ± 5% RH. The results indicated that our formulation can be stored at 30°C ± 2°C/75% RH for 30 days, which will very well serve the need to allow drug distribution and patient use during the crisis, while the shelf-life can be extended to 60 days when stored at 5°C ± 3°C. Thus, accessibility to an essential medical treatment has been successfully enhanced for pediatric patients in Thailand and neighboring countries during the COVID-19 outbreak.",
        "pubmed-id": "36334809",
        "prism:coverDate": "2023-02-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85142751937",
        "dc:creator": {"author": [{
            "ce:given-name": "Bodin",
            "preferred-name": {
                "ce:given-name": "Bodin",
                "ce:initials": "B.",
                "ce:surname": "Tuesuwan",
                "ce:indexed-name": "Tuesuwan B."
            },
            "@seq": "1",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Tuesuwan",
            "@auid": "6504614303",
            "author-url": "https://api.elsevier.com/content/author/author_id/6504614303",
            "ce:indexed-name": "Tuesuwan B."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85142751937"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85142751937&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85142751937&origin=inward"
            }
        ],
        "source-id": "23079",
        "pii": "S0022354922005081",
        "citedby-count": "0",
        "prism:volume": "112",
        "subtype": "ar",
        "dc:title": "Basis to Aid Crisis: Favipiravir Oral Solution for Hospital Compounding During COVID-19 Drug Shortage",
        "openaccess": "2",
        "prism:issn": "15206017 00223549",
        "publishercopyright": "© 2022 American Pharmacists Association",
        "prism:issueIdentifier": "2",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of Pharmaceutical Sciences",
        "prism:pageRange": "610-617",
        "prism:endingPage": "617",
        "openaccessFlag": null,
        "prism:doi": "10.1016/j.xphs.2022.10.026",
        "prism:startingPage": "610",
        "dc:identifier": "SCOPUS_ID:85142751937",
        "dc:publisher": "Elsevier B.V."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Amides",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Child",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "COVID-19",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Drug Compounding",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Drug Stability",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hospitals",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Pandemics",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "COVID-19"
        },
        {
            "@_fa": "true",
            "$": "Favipiravir"
        },
        {
            "@_fa": "true",
            "$": "Formulation development"
        },
        {
            "@_fa": "true",
            "$": "Hospital compounding"
        },
        {
            "@_fa": "true",
            "$": "Oral solution"
        },
        {
            "@_fa": "true",
            "$": "Specification"
        },
        {
            "@_fa": "true",
            "$": "Stability"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Pharmaceutical Science",
        "@code": "3003",
        "@abbrev": "PHAR"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Bodin",
            "preferred-name": {
                "ce:given-name": "Bodin",
                "ce:initials": "B.",
                "ce:surname": "Tuesuwan",
                "ce:indexed-name": "Tuesuwan B."
            },
            "@seq": "1",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Tuesuwan",
            "@auid": "6504614303",
            "author-url": "https://api.elsevier.com/content/author/author_id/6504614303",
            "ce:indexed-name": "Tuesuwan B."
        },
        {
            "ce:given-name": "Wunlapa",
            "preferred-name": {
                "ce:given-name": "Wunlapa",
                "ce:initials": "W.",
                "ce:surname": "Mueannoom",
                "ce:indexed-name": "Mueannoom W."
            },
            "@seq": "2",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "127008786",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127008786"
            },
            "ce:surname": "Mueannoom",
            "@auid": "36340610800",
            "author-url": "https://api.elsevier.com/content/author/author_id/36340610800",
            "ce:indexed-name": "Mueannoom W."
        },
        {
            "ce:given-name": "Promporn",
            "preferred-name": {
                "ce:given-name": "Promporn",
                "ce:initials": "P.",
                "ce:surname": "Jamnongtanachot",
                "ce:indexed-name": "Jamnongtanachot P."
            },
            "@seq": "3",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "127008786",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127008786"
            },
            "ce:surname": "Jamnongtanachot",
            "@auid": "57812104000",
            "author-url": "https://api.elsevier.com/content/author/author_id/57812104000",
            "ce:indexed-name": "Jamnongtanachot P."
        },
        {
            "ce:given-name": "Ariya",
            "preferred-name": {
                "ce:given-name": "Ariya",
                "ce:initials": "A.",
                "ce:surname": "Khunvichai",
                "ce:indexed-name": "Khunvichai A."
            },
            "@seq": "4",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "127008786",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127008786"
            },
            "ce:surname": "Khunvichai",
            "@auid": "24179362700",
            "author-url": "https://api.elsevier.com/content/author/author_id/24179362700",
            "ce:indexed-name": "Khunvichai A."
        },
        {
            "ce:given-name": "Chiravi",
            "preferred-name": {
                "ce:given-name": "Chiravi",
                "ce:initials": "C.",
                "ce:surname": "Pavitrapok",
                "ce:indexed-name": "Pavitrapok C."
            },
            "@seq": "5",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "127008786",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127008786"
            },
            "ce:surname": "Pavitrapok",
            "@auid": "12244858700",
            "author-url": "https://api.elsevier.com/content/author/author_id/12244858700",
            "ce:indexed-name": "Pavitrapok C."
        },
        {
            "ce:given-name": "Kawinthida",
            "preferred-name": {
                "ce:given-name": "Kawinthida",
                "ce:initials": "K.",
                "ce:surname": "Wongpakdee",
                "ce:indexed-name": "Wongpakdee K."
            },
            "@seq": "6",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022464",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022464"
            },
            "ce:surname": "Wongpakdee",
            "@auid": "57812103900",
            "author-url": "https://api.elsevier.com/content/author/author_id/57812103900",
            "ce:indexed-name": "Wongpakdee K."
        },
        {
            "ce:given-name": "Supasil",
            "preferred-name": {
                "ce:given-name": "Supasil",
                "ce:initials": "S.",
                "ce:surname": "Sra-ium",
                "ce:indexed-name": "Sra-ium S."
            },
            "@seq": "7",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022464",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022464"
            },
            "ce:surname": "Sra-ium",
            "@auid": "23092189800",
            "author-url": "https://api.elsevier.com/content/author/author_id/23092189800",
            "ce:indexed-name": "Sra-ium S."
        },
        {
            "ce:given-name": "Nithi",
            "preferred-name": {
                "ce:given-name": "Nithi",
                "ce:initials": "N.",
                "ce:surname": "Mahanonda",
                "ce:indexed-name": "Mahanonda N."
            },
            "@seq": "8",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022464",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022464"
            },
            "ce:surname": "Mahanonda",
            "@auid": "7007170188",
            "author-url": "https://api.elsevier.com/content/author/author_id/7007170188",
            "ce:indexed-name": "Mahanonda N."
        },
        {
            "ce:given-name": "Vorasit",
            "preferred-name": {
                "ce:given-name": "Vorasit",
                "ce:initials": "V.",
                "ce:surname": "Vongsutilers",
                "ce:indexed-name": "Vongsutilers V."
            },
            "@seq": "9",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Vongsutilers",
            "@auid": "36783652300",
            "author-url": "https://api.elsevier.com/content/author/author_id/36783652300",
            "ce:indexed-name": "Vongsutilers V."
        }
    ]}
}}